Skip to Content
Shahab Akhter, MD

Surgical Services

Contact Dr. Akhter


(608) 263-6551

H4/340A CSC
MADISON, WI 53792-0001

Shahab Akhter, MD

Chairman, Division of Cardiothoracic Surgery


  • MD, University of Chicago-Pritzker School of Medicine, Chicago, Illinois, 1993
  • Residency in General Surgery, Duke University Medical Center, Durham, North Carolina, 2000
  • Residency in Cardiothoracic Surgery, University of Michigan Medical Center, Ann Arbor, MI, 2002

Clinical Specialties

Dr. Akhter is certified by the American Board of Surgery and the American Board of Thoracic Surgery. He specializes in complex and high-risk cardiac surgery in adults. His particular areas of expertise include mitral and tricuspid valve repair, ventricular assist devices and heart transplantation, minimally invasive surgery for the treatment of atrial fibrillation, and re-operative cardiac surgery. Dr. Akhter also performs coronary artery bypass grafting, minimally invasive valve surgery, and transcatheter valve replacement.

Dr. Akhter provides a wide range of services including Angioplasty, Aortic Valve-Sparing Surgery, Aortic Valve-Sparing Surgery, Atrial Septal Defect (ASD) Repair, Atrial Septal Defect (ASD) Repair, Cardiac Resynchronization Therapy (CRT), Cardioversion, Carotid and Peripheral Blood Vessel Revascularization, Carotid Artery Stent, Carotid Surgery and Intervention, Cryoablation, Destination Therapy for End-Stage Heart Failure, Endoscopic Surveillance, Heart Bypass (Coronary Artery Bypass Graft Surgery - CABG), In Situ Vein Bypass for Limb Salvage, Limb Salvage, Maze Procedure (Minimally Invasive), Mitral Valve Repair, Pacemakers, Photodynamic Therapy, (show all).

Research Interests

Dr. Akhter’s clinical research focuses on optimizing outcomes in mechanical circulatory support for advanced heart failure and developing novel approaches for minimally invasive arrhythmia surgery. His laboratory research program investigates molecular mechanisms involved in the development of heart failure with the goal of discovering novel therapeutic strategies to prevent this disease process.

Recent Publications
  • Impact of age on outcomes following continuous-flow left ventricular assist device implantation.
    Lushaj EB, Badami A, Osaki S, Murray M, Leverson G, Lozonschi L, Akhter S, Kohmoto T
    Interact Cardiovasc Thorac Surg 2015 Mar 13.
    [PubMed ID: 25770085]
    More Information
  • Reduction in driveline infection rates: Results from the HeartMate II Multicenter Driveline Silicone Skin Interface (SSI) Registry.
    Dean D, Kallel F, Ewald GA, Tatooles A, Sheridan BC, Brewer RJ, Caldeira C, Farrar DJ, Akhter SA, on Behalf of the SSI Registry Investigators
    J. Heart Lung Transplant. 2014 Dec 5.
    [PubMed ID: 25735901]
    More Information
  • Modified HeartMate II driveline externalization technique significantly decreases incidence of infection and improves long-term survival.
    Singh A, Russo MJ, Valeroso TB, Anderson AS, Rich JD, Jeevanandam V, Akhter SA
    ASAIO J. 2014 Nov-Dec; 60(6):613-6.
    [PubMed ID: 25072552]
    More Information
  • High-molecular-weight polyethylene glycol inhibits myocardial ischemia-reperfusion injury in vivo.
    Xu X, Philip JL, Razzaque MA, Lloyd JW, Muller CM, Akhter SA
    J. Thorac. Cardiovasc. Surg. 2015 Feb; 149(2):588-93.
    [PubMed ID: 25455467]
    More Information
  • Connexin40 abnormalities and atrial fibrillation in the human heart.
    Gemel J, Levy AE, Simon AR, Bennett KB, Ai X, Akhter S, Beyer EC
    J. Mol. Cell. Cardiol. 2014 Nov; 76():159-68.
    [PubMed ID: 25200600, PMC ID: 4250516]
    More Information
  • β-Arrestins regulate human cardiac fibroblast transformation and collagen synthesis in adverse ventricular remodeling.
    Li J, Philip JL, Xu X, Theccanat T, Abdur Razzaque M, Akhter SA
    J. Mol. Cell. Cardiol. 2014 Nov; 76():73-83.
    [PubMed ID: 25134464, PMC ID: 4250404]
    More Information
  • Functional evaluation of human donation after cardiac death donor hearts using a continuous isolated myocardial perfusion technique: Potential for expansion of the cardiac donor population.
    Osaki S, Locher MR, Lushaj EB, Akhter SA, Kohmoto T
    J. Thorac. Cardiovasc. Surg. 2014 Sep; 148(3):1123-30; discussion 1130.
    [PubMed ID: 25129607]
    More Information
  • Durability of De Vega tricuspid valve annuloplasty for severe tricuspid regurgitation during left ventricular assist device implantation.
    Akhter SA, Salabat MR, Philip JL, Valeroso TB, Russo MJ, Rich JD, Jeevanandam V
    Ann. Thorac. Surg. 2014 Jul; 98(1):81-3.
    [PubMed ID: 24820391]
    More Information
  • Acute kidney injury and mortality following ventricular assist device implantation.
    Naik A, Akhter SA, Fedson S, Jeevanandam V, Rich JD, Koyner JL
    Am. J. Nephrol. 2014; 39(3):195-203.
    [PubMed ID: 24556808, PMC ID: 4000722]
    More Information
  • Transapical approach for mitral valve repair during insertion of a left ventricular assist device.
    Russo MJ, Merlo A, Johnson EM, Akhter S, McCarney S, Steiman J, Anderson A, Jeevanandam V
    ScientificWorldJournal 2013; 2013():925310.
    [PubMed ID: 23878531, PMC ID: 3710651]
    More Information Copyright © 2015 The Board of Regents of the University of Wisconsin System